Intravitreal Celecoxib for Chronic Uveitis: A Phase I Investigational Safety Study
Phase of Trial: Phase I
Latest Information Update: 28 Feb 2017
Price : $35 *
At a glance
- Drugs Celecoxib (Primary)
- Indications Uveitis
- Focus Adverse reactions
- 20 Feb 2017 Status changed from not yet recruiting to discontinued.
- 08 Dec 2015 Planned End Date changed from 1 Jun 2016 to 1 Jun 2017 as reported by ClinicalTrials.gov.
- 08 Dec 2015 Planned initiation date changed from 1 May 2014 to 1 Jun 2015 as reported by ClinicalTrials.gov.